The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents
IBRO Reports · 2019-06 · 6 · 95-110
DOI: 10.1016/j.ibror.2019.01.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift IBRO Reports, 2019-06. Verfasst von Olumuyiwa John Fasipe. Beteiligte Einrichtung: Medical Lecturer and Senior Physician, Department of Clinical Pharmacology and Therapeutics, Faculty of Basic Clinical Sciences, University of Medica…. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Lecturer and Senior Physician, Department of Clinical Pharmacology and Therapeutics, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo City, Ondo State, Nigeria.
Zitieren
APA
Fasipe, O. J. (2019). The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents. IBRO Reports, 6, 95-110. https://doi.org/10.1016/j.ibror.2019.01.001
Vancouver
Fasipe OJ. The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents. IBRO Reports. 2019;6:95-110. doi:10.1016/j.ibror.2019.01.001
BibTeX
@article{Fasipe2019,
author = {Fasipe, Olumuyiwa John},
title = {The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents},
journal = {IBRO Reports},
year = {2019},
volume = {6},
pages = {95--110},
doi = {10.1016/j.ibror.2019.01.001}
}
EUVIMED